-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)
-
-
-
-
-
-
-
Genmab A/S (GMAB) PT Raised to $34 at H.C. Wainwright After DARZALEX Combo Results
-
-
-
-
-
-
-
Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States
-
21,519 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

